{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:18:09Z","timestamp":1793830689116,"version":"4.6.1"},"reference-count":40,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2010,3,10]],"date-time":"2010-03-10T00:00:00Z","timestamp":1268179200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Addiction"],"published-print":{"date-parts":[[2010,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p><jats:bold>Background\u2003<\/jats:bold> Sublingual buprenorphine is an effective maintenance treatment for opioid dependence, yet intravenous buprenorphine misuse occurs. A buprenorphine\/naloxone formulation was developed to mitigate this misuse risk. This randomized, double\u2010blind, cross\u2010over study was conducted to assess the intravenous abuse potential of buprenorphine\/naloxone compared with buprenorphine in buprenorphine\u2010maintained injection drug users (IDUs).<\/jats:p><jats:p><jats:bold>Methods\u2003<\/jats:bold> Intravenous heroin users (<jats:italic>n<\/jats:italic>\u2003=\u200312) lived in the hospital for 8\u20139 weeks and were maintained on each of three different sublingual buprenorphine doses (2\u2003mg, 8\u2003mg, 24\u2003mg). Under each maintenance dose, participants completed laboratory sessions during which the reinforcing and subjective effects of intravenous placebo, naloxone, heroin and low and high doses of buprenorphine and buprenorphine\/naloxone were examined. Every participant received each test dose under the three buprenorphine maintenance dose conditions.<\/jats:p><jats:p><jats:bold>Results\u2003<\/jats:bold> Intravenous buprenorphine\/naloxone was self\u2010administered less frequently than buprenorphine or heroin (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.0005). Participants were most likely to self\u2010administer drug intravenously when maintained on the lowest sublingual buprenorphine dose. Subjective ratings of \u2018drug liking\u2019 and \u2018desire to take the drug again\u2019 were lower for buprenorphine\/naloxone than for buprenorphine or heroin (<jats:italic>P<\/jats:italic>\u2003=\u20030.0001). Participants reported that they would pay significantly less money for buprenorphine\/naloxone than for buprenorphine or heroin (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.05). Seven adverse events were reported; most were mild and transient.<\/jats:p><jats:p><jats:bold>Conclusions\u2003<\/jats:bold> These data suggest that although the buprenorphine\/naloxone combination has intravenous abuse potential, that potential is lower than it is for buprenorphine alone, particularly when participants received higher maintenance doses and lower buprenorphine\/naloxone challenge doses. Buprenorphine\/naloxone may be a reasonable option for managing the risk for buprenorphine misuse during opioid dependence treatment.<\/jats:p>","DOI":"10.1111\/j.1360-0443.2009.02843.x","type":"journal-article","created":{"date-parts":[[2010,3,10]],"date-time":"2010-03-10T12:31:43Z","timestamp":1268224303000},"page":"709-718","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":93,"title":["Abuse liability of intravenous buprenorphine\/naloxone and buprenorphine alone in buprenorphine\u2010maintained intravenous heroin abusers"],"prefix":"10.1111","volume":"105","author":[{"given":"Sandra D.","family":"Comer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne K.","family":"Vosburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne","family":"Manubay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Amass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziva D.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Saccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert D.","family":"Kleber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,3,10]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1086\/508184"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2007.02029.x"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61311-2"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1080\/09540120220097955"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2003.00296.x"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0740-5472(03)00130-2"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002207.pub3"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2004.00963.x"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-007-0046-2"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200011023431802"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2006.09.012"},{"key":"e_1_2_8_13_2","first-page":"919","article-title":"Tackling Subutex abuse in Singapore","volume":"47","author":"Lee C. E.","year":"2006","journal-title":"Singapore Med J"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2001.96226710.x"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1186\/1747-597X-3-16"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022164"},{"key":"e_1_2_8_17_2","article-title":"Buprenorphine\u2013naloxone (8\/2\u2003mg and 16\/4\u2003mg) versus methadone (45\u2003mg and 90\u2003mg) maintenance therapy: a randomised double\u2010blind trial with opioid dependent patients","author":"Kamien J. B.","year":"2010","journal-title":"Heroin Addiction Related Clinical Problems"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002130000637"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(98)00008-8"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00212842"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1989.10"},{"key":"e_1_2_8_22_2","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1994"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002130050956"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.3758\/BF03203313"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1159\/000118441"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2008.03.025"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2003.11.017"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(03)00059-0"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-119-1-199307010-00004"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(93)90052-R"},{"key":"e_1_2_8_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(97)01347-1"},{"key":"e_1_2_8_32_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.105.090423"},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2008.03.001"},{"key":"e_1_2_8_34_2","volume-title":"Diversion and Abuse of Buprenorphine: A Brief Assessment of Emerging Indicators: Final Report","author":"JBS International, Inc.","year":"2006"},{"key":"e_1_2_8_35_2","doi-asserted-by":"publisher","DOI":"10.1080\/10550490701860971"},{"key":"e_1_2_8_36_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa055255"},{"key":"e_1_2_8_37_2","doi-asserted-by":"publisher","DOI":"10.1080\/10550490490440799"},{"key":"e_1_2_8_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2004.00958.x"},{"key":"e_1_2_8_39_2","doi-asserted-by":"publisher","DOI":"10.1080\/09595230701829553"},{"key":"e_1_2_8_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2007.01979.x"},{"key":"e_1_2_8_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2008.02.012"}],"updated-by":[{"DOI":"10.1111\/j.1360-0443.2010.03083_1.x","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2010,6,8]],"date-time":"2010-06-08T00:00:00Z","timestamp":1275955200000}}],"container-title":["Addiction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1360-0443.2009.02843.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1360-0443.2009.02843.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T08:24:37Z","timestamp":1697531077000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1360-0443.2009.02843.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,10]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["10.1111\/j.1360-0443.2009.02843.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1360-0443.2009.02843.x","archive":["Portico"],"relation":{"erratum":[{"id-type":"doi","id":"10.1111\/j.1360-0443.2010.03083_1.x","asserted-by":"object"}]},"ISSN":["0965-2140","1360-0443"],"issn-type":[{"value":"0965-2140","type":"print"},{"value":"1360-0443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,10]]},"assertion":[{"value":"2010-03-10","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}